SCHEMBL76227

SCHEMBL76227

CCCCCCCCCCCCCCCCCC(N)CC(O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 2/20 0.54
S1PR2 O95136 5/20 0.50
S1PR1 P21453 5/20 0.50
S1PR3 Q99500 5/20 0.50
S1PR4 O95977 4/20 0.50
CYP2D6 P10635 2/20 0.50
PLA2G1B P04054 1/20 0.50
PLA2G2A P14555 1/20 0.50
GMNN O75496 1/20 0.50
LMNA P02545 1/20 0.50
POLB P06746 1/20 0.50
THPO P40225 1/20 0.50
MTOR P42345 1/20 0.50
BLM P54132 1/20 0.50
KDM4E B2RXH2 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
CETP P11597 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6942454 1.00 SPHK1 (0.54) SPHK1S1PR2S1PR1S1PR3S1PR4
SCHEMBL3678209 1.00 SPHK1 (0.54) SPHK1S1PR2S1PR1S1PR3S1PR4
SCHEMBL3676653 1.00 SPHK1 (0.54) SPHK1S1PR2S1PR1S1PR3S1PR4
Hydrochloric Acid SCHEMBL28157784 0.98 SPHK1 (0.52) SPHK1S1PR2S1PR1S1PR3S1PR4
SCHEMBL6727149 0.98 SPHK1 (0.50) SPHK1S1PR2S1PR1S1PR3S1PR4
SCHEMBL11050257 0.89 MEN1 (0.47) SPHK1S1PR2S1PR1S1PR3S1PR4
SCHEMBL27570387 0.85 PLA2G1B (0.58) SPHK1S1PR2S1PR1S1PR3S1PR4
SCHEMBL27570383 0.85 PLA2G1B (0.58) SPHK1S1PR2S1PR1S1PR3S1PR4
SCHEMBL8688268 0.84 SPHK1 (0.57) SPHK1S1PR2S1PR1S1PR3S1PR4
SCHEMBL8686851 0.84 SPHK1 (0.57) SPHK1S1PR2S1PR1S1PR3S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070256987-A1 Chemically-enhanced mechanical treatment of water AQUALON COMPANY 2007-11-08 US claimed
WO-2007075681-A1 CHEMICALLY-ENHANCED MECHANICAL TREATMENT OF WATER HERCULES INCORPORATED (US) 2007-07-05 WO claimed
US-6794427-B2 CATIONIC SUBSTANCE AND A NONIONIC POLYMERIC SUBSTANCE, WHICH IS COLORLESS OR PALE-COLORED CANON KABUSHIKI KAISHA (JP) 2004-09-21 US claimed
EP-1392232-A2 COSMETIC COMPOSITIONS CONTAINING HETEROPOLYMERS AND OIL-SOLUBLE CATIONIC SURFACTANTS AND METHODS OF USING SAME l'Oreal SA (FR) 2004-03-03 EP claimed
EP-1339374-A2 COMPOSITIONS CONTAINING HETEROPOLYMERS AND METHODS OF USING SAME l'Oreal SA (FR) 2003-09-03 EP claimed
US-20030082126-A9 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same L'OREAL S.A. (FR) 2003-05-01 US claimed
US-6500523-B1 INK ABSORBENT SHEET WITH INORGANIC PIGMENT AND BINDER GLOSSY SIDE AND CATIONIC COMPOUND OR POLYMER IMPREGNATED REVERSE SIDE; POST CARDS; INK JET PRINTABILITY CANON KABUSHIKI KAISHA (JP) 2002-12-31 US claimed
US-20020122781-A1 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same PINZON CARLOS O (US) 2002-09-05 US claimed
WO-2002047620-A2 COMPOSITIONS CONTAINING HETEROPOLYMERS AND METHODS OF USING SAME L'OREAL SA (FR) 2002-06-20 WO claimed
WO-2002047658-A2 COSMETIC COMPOSITIONS CONTAINING HETEROPOLYMERS AND OIL-SOLUBLE CATIONIC SURFACTANTS AND METHODS OF USING SAME L'OREAL SA (FR) 2002-06-20 WO claimed
US-6325501-B2 Ink-jet printing cloth, printing process using the same and print obtained by the process CANON KABUSHIKI KAISHA (JP) 2001-12-04 US claimed
EP-0661168-B1 Recording medium and image-forming method employing the same CANON KK (JP) 2001-10-31 EP claimed
EP-0663299-B1 Liquid composition and ink set, and image-forming process and apparatus using the same CANON KK (JP) 2000-08-30 EP claimed
US-6022383-A Processes for coloring leather by an ink-jet printing method using anionic coloring agents and cationic agents, and leather products obtained therewith CANON KABUSHIKI KAISHA (JP) 2000-02-08 US claimed
EP-0709220-B1 Recording medium, and image forming method employing the same CANON KK (JP) 1999-02-10 EP claimed
US-3968104-A SOLVENTS BAYER AKTIENGESELLSCHAFT (DT) 1976-07-06 US claimed
JP-3261710-A None JP disclosed
EP-4739653-A1 COMPOSITIONS AND METHODS AND USES RELATED THERETO Innospec Limited (GB) 2026-05-13 EP disclosed
US-3974128-A HAIR SPRAY THE GILLETTE COMPANY (US) 1976-08-10 US disclosed
US-3968104-A SOLVENTS BAYER AKTIENGESELLSCHAFT (DT) 1976-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020122781-A1 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same SYMPK, CUTA, LSS SPHK1 56/4885S1PR2 1177/4885S1PR1 1457/4885
US-20030082126-A9 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same SYMPK, CUTA, LSS SPHK1 56/4885S1PR2 1177/4885S1PR1 1457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.